XBiotech Stock Price - XBIT

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
XBiotech Inc XBIT NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -1.29 -5.31% 23.01 24.00 22.43 23.96 24.30 20:00:00
Bid Price Ask Price Spread Spread % News
20.83 24.00 3.17 13.21% 1 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
11,417 1,472,405 $ 23.13 $ 34,052,212 869,821 5.408 - 33.20
Last Trade Time Type Quantity Stock Price Currency
19:22:33 99 $ 23.01 USD

XBiotech Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 945.40M 41.09M $ -21.14M -0.58 - 25.92M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

XBiotech News

Loading Messages....

Latest XBIT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical XBIT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week24.6531.8518.8724.513,093,304-1.64-6.65%
1 Month19.9531.8517.8023.12904,8713.0615.34%
3 Months10.1833.2010.1019.91554,67912.83126.03%
6 Months7.2133.206.8417.41318,24915.80219.14%
1 Year6.1533.205.40814.52243,55316.86274.15%
3 Years11.7533.202.1310.08176,44111.2695.83%
5 Years23.0033.202.1312.01177,6010.010.04%

XBiotech Description

XBiotech Inc is an US based clinical-stage biopharmaceutical company which is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing MABp1 a therapeutic antibody as a treatment for cancer. It has developed therapeutic antibody Xilonix which is being evaluated as a monotherapy to treat advanced stages of colorectal cancer. Xilonix neutralizes a pro-inflammatory protein produced by leukocytes and other cells.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.